Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Relationship between serum parathyroid hormone levels and lipid profile in non-diabetic hemodialysis patients.

Ahmadi F, Mirjafari SR, Khatami Mr, Khazaeipour Z, Ranjbarnovin N.

Saudi J Kidney Dis Transpl. 2012 Nov;23(6):1188-95. doi: 10.4103/1319-2442.103558.

2.
3.

Correlation of serum magnesium with dyslipidemia in patients on maintenance hemodialysis.

Ansari MR, Maheshwari N, Shaikh MA, Laghari MS; Darshana, Lal K, Ahmed K.

Saudi J Kidney Dis Transpl. 2012 Jan;23(1):21-5.

5.

The uremic dyslipidemia: a cross-sectional and longitudinal study.

Avram MM, Goldwasser P, Burrell DE, Antignani A, Fein PA, Mittman N.

Am J Kidney Dis. 1992 Oct;20(4):324-35.

PMID:
1415199
6.

Correlation of serum magnesium with serum parathormone levels in patients on regular hemodialysis.

Baradaran A, Nasri H.

Saudi J Kidney Dis Transpl. 2006 Sep;17(3):344-50.

7.

Relationship between serum parathyroid hormone levels and lipid profile in hemodialysis patients. Evolution of lipid parameters after parathyroidectomy.

Navarro JF, Teruel JL, Lasunción MA, Mora-Fernandez C, Ortuño J.

Clin Nephrol. 1998 May;49(5):303-7.

PMID:
9617494
8.

Prevalence of 25(OH) vitamin D insufficiency and deficiency in chronic kidney disease stage 5 patients on hemodialysis.

Del Valle E, Negri AL, Aguirre C, Fradinger E, Zanchetta JR.

Hemodial Int. 2007 Jul;11(3):315-21.

PMID:
17576296
9.

Comparison of efficacy of the phosphate binders nicotinic acid and sevelamer hydrochloride in hemodialysis patients.

Ahmadi F, Shamekhi F, Lessan-Pezeshki M, Khatami MR.

Saudi J Kidney Dis Transpl. 2012 Sep;23(5):934-8. doi: 10.4103/1319-2442.100865.

11.

Pattern of lipid profile in patients on maintenance hemodialysis.

Maheshwari N, Ansari MR, Darshana MS, Lal K, Ahmed K.

Saudi J Kidney Dis Transpl. 2010 May;21(3):565-70.

12.

The role of clinical pharmacy services in achieving treatment targets in Iranian haemodialysis patients.

Dashti-Khavidaki S, Khalili H, Shahverdi S, Abbasi MR, Lessan-Pezeshki M.

Singapore Med J. 2012 Sep;53(9):599-603.

13.
15.

Post-parathyroidectomy serum phosphate kinetics is peculiar to female hemodialysis patients with a high body mass index.

Lomonte C, Vernaglione L, Cazzato F, Casucci F, Chimienti D, Bruno A, Cocola S, Basile C.

J Nephrol. 2006 Jan-Feb;19(1):70-6.

PMID:
16523429
16.

Age-related decline in serum parathyroid hormone in maintenance hemodialysis patients is independent of inflammation and dietary nutrient intake.

Mehrotra R, Supasyndh O, Berman N, Kaysen G, Hurst L, Leonardi M, Das D, Kopple JD.

J Ren Nutr. 2004 Jul;14(3):134-42.

PMID:
15232791
17.

Significance of serum magnesium as an independent correlative factor on the parathyroid hormone level in uremic patients.

Ohya M, Negi S, Sakaguchi T, Koiwa F, Ando R, Komatsu Y, Shinoda T, Inaguma D, Joki N, Yamaka T, Ikeda M, Shigematsu T.

J Clin Endocrinol Metab. 2014 Oct;99(10):3873-8. doi: 10.1210/jc.2013-4396. Epub 2014 Jun 17.

PMID:
24937533
18.

[Bone biomarkers in haemodialysis patients: bone alkaline phosphatase or ß-Crosslaps?].

Jean G, Souberbielle JC, Granjon S, Lorriaux C, Hurot JM, Mayor B, Deleaval P, Chazot C.

Nephrol Ther. 2013 Jun;9(3):154-9. doi: 10.1016/j.nephro.2013.02.006. Epub 2013 Mar 29. French.

PMID:
23545236
19.
20.

Assessment of phosphorus and calcium metabolism and its clinical management in hemodialysis patients in the community of Valencia.

Maduell F, Gorriz JL, Pallardo LM, Pons R, Santiago C; Multicentric group for the study of the phosphocalcic metabolism in the community of Valencia.

J Nephrol. 2005 Nov-Dec;18(6):739-48.

PMID:
16358233

Supplemental Content

Support Center